We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current LNSR market cap is 169.06M. The company's latest EPS is USD -1.2200 and P/E is -11.76.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.8M | 12.11M | 10.59M | 12.64M | 13.54M |
| Operating Income | -2.04M | -2.96M | -2.85M | -5.28M | -1.25M |
| Net Income | 2.57M | -3.93M | -2.16M | -9.04M | -1.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 30.53M | 26.38M | 34.46M | 35.36M | 42.16M |
| Operating Income | -12.71M | -18.5M | -19.65M | -20.18M | -12.23M |
| Net Income | -14.66M | -19.77M | -19.6M | -19.91M | -14.38M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 70.85M | 69.59M | 66.13M | 61.41M | 62.02M |
| Total Liabilities | 20.72M | 22.41M | 20.55M | 23.98M | 25.5M |
| Total Equity | 36.38M | 33.43M | 31.84M | 23.65M | 22.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 34.54M | 79.12M | 66.47M | 55.84M | 69.59M |
| Total Liabilities | 65.09M | 11.91M | 11.59M | 13.86M | 22.41M |
| Total Equity | -30.55M | 67.21M | 54.88M | 41.98M | 33.43M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.18M | -9.66M | -5.31M | -9.09M | -5.93M |
| Investing | -191k | -4.16M | -1.23M | -3.25M | -4.15M |
| Financing | 19.62M | 19.76M | -130k | -1,000 | -94k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.59M | -13.79M | -8.97M | -14.86M | -9.66M |
| Investing | -2.09M | -326k | -354k | -115k | -4.16M |
| Financing | 15.95M | 50M | 361k | -1.99M | 19.76M |
| Market Cap | 169.06M |
| Price to Earnings Ratio | -11.76 |
| Price to Sales Ratio | 4.01 |
| Price to Cash Ratio | 8.2 |
| Price to Book Ratio | 3.59 |
| Dividend Yield | - |
| Shares Outstanding | 11.79M |
| Average Volume (1 week) | 188.47k |
| Average Volume (1 Month) | 127.04k |
| 52 Week Change | 242.24% |
| 52 Week High | 16.40 |
| 52 Week Low | 2.67 |
| Spread (Intraday) | 0.27 (1.87%) |
| Company Name | LENSAR Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.lensar.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
